A detailed history of Krs Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Krs Capital Management, LLC holds 3,957 shares of AMGN stock, worth $1.27 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
3,957
Previous 4,033 1.88%
Holding current value
$1.27 Million
Previous $1.26 Million 1.11%
% of portfolio
0.93%
Previous 0.95%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $23,512 - $25,640
-76 Reduced 1.88%
3,957 $1.27 Million
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $10,247 - $12,453
-39 Reduced 0.96%
4,033 $1.26 Million
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $215,633 - $260,297
802 Added 24.53%
4,072 $1.16 Million
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $107,394 - $121,153
420 Added 14.74%
3,270 $941,000
Q3 2023

Oct 19, 2023

BUY
$218.65 - $271.46 $32,141 - $39,904
147 Added 5.44%
2,850 $765,000
Q2 2023

Jul 14, 2023

BUY
$214.27 - $253.37 $10,284 - $12,161
48 Added 1.81%
2,703 $600,000
Q1 2023

Apr 11, 2023

BUY
$225.79 - $275.2 $116,959 - $142,553
518 Added 24.24%
2,655 $641,000
Q4 2022

Jan 19, 2023

BUY
$229.03 - $291.01 $13,741 - $17,460
60 Added 2.89%
2,137 $0
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $20,874 - $23,542
93 Added 4.69%
2,077 $468,000
Q2 2022

Aug 02, 2022

BUY
$230.71 - $256.74 $461 - $513
2 Added 0.1%
1,984 $482,000
Q1 2022

Apr 27, 2022

SELL
$219.27 - $242.57 $10,305 - $11,400
-47 Reduced 2.32%
1,982 $479,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $403,527 - $461,800
2,029 New
2,029 $456,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Krs Capital Management, LLC Portfolio

Follow Krs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.